학술논문
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: Results from the british isles lupus assessment group biologics register
Document Type
Article
Author
McCarthy, E.M.; Parker, B.; Bruce, I.N.; Sutton, E.; Nesbit, S.; White, J.; Jayne, D.; Griffiths, B.; Isenberg, W.A.; Rahman, A.; Gordon, C.; D'Cruz, D.P.; Rhodes, B.; Lanyon, P.; Vital, E.M.; Yee, C.-S.; Edwards, C.J.; Teh, L.-S.; Akil, M.; McHugh, N.J.; Zoma, A.; Gordon, P.; Young-Min, S.; Stevens, R.; Prabu, A.; Batley, M.; Gendi, N.; Dasgupta, B.; Khamashta, M.; Hewins, P.; Stratton, R.J.; Chan, A.; De Lord, D.; King, J.; Dubey, S.; O'Riordan, E.; Shaffu, S.; Laversuch, C.; Sheeran, T.P.; Vermaak, E.; Erb, N.; Pyne, D.; Jeffrey, R.; Youssef, H.; Al-Allaf, W.; Regan, M.; Kaul, A.
Source
In: Rheumatology (United Kingdom) . (Rheumatology (United Kingdom), 1 March 2018, 57(3):470-479)
Subject
Language
English
ISSN
14620332
14620324
14620324